UnitedHealth Group's stock surged after beating Q2 earnings estimates and providing strong guidance. This positive performance highlights a significant missed opportunity for Berkshire Hathaway, which had completely sold its UNH position in Q1 2026 under new CEO Greg Abel, foregoing substantial gains.
UnitedHealth Group (UNH) reported strong Q2 earnings and raised guidance, causing its stock to rally. This event is significant because Berkshire Hathaway (BRK-A, BRK-B), under new CEO Greg Abel, had completely divested its UNH stake in Q1 2026, missing out on a potential nine-figure gain. This highlights the immediate positive impact for existing UNH shareholders and a substantial opportunity cost for Berkshire Hathaway, raising questions about the new leadership's investment decisions compared to Warren Buffett's tenure. The short-term implication is a boost for UNH and a 'what if' scenario for BRK, while long-term, it puts pressure on Abel to demonstrate successful portfolio management.